News search
Research 21 Dec 2023 Johns Hopkins UniversityBloomberg School of Public HealthBaltimore |
About the CNIC 19 Dec 2023 Dr. Carla Rothlin is Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at the Yale School of Medicine, and co-leader of the Cancer Immunology Programme at Yale Cancer Centre. She studied biochemistry and pharmacology at the University of Buenos Aires, where she also undertook her postgraduate research under the direction of Dr. Ana Belén Elgoyhen, focussing on nicotinic receptors expressed in the inner ear. Later, she completed her doctorate and moved to San Diego to join Dr. Greg Lemke’s laboratory at the Salk Institute for Biological Studies. In 2009, Dr. Rothlin was named Assistant Professor in Immunobiology at Yale Medical School |
About the CNIC 17 Nov 2023 This work is of fundamental importance for understanding the immune system and its reactions |
About the CNIC 30 Oct 2023 The Honorific Award for Excellence in Scientific Research is awarded in recognition of the career of scientists who have contributed to the generation of knowledge and advances in their field of specialization |
About the CNIC 27 Oct 2023 |
About the CNIC 8 Aug 2023 |
Research 21 May 2023 The team led by Dr. Pablo García-Pavía, based at the CNIC and Hospital Puerta de Hierro, has published the first study of a drug able to remove amyloid deposits from the heart |
Research 3 Oct 2022 Metoprolol, an established drug in the cardiologists armory, protects the brain during a stroke and greatly reduces its consequences |
About the CNIC 19 Sep 2022 CNIC's leader have been recognized for his exceptional career achievements at the 34th annual conference |
Research 29 Aug 2022 The findings, published in the Journal of the American College of Cardiology (JACC), represent a first step towards the personalized treatment of patients with this disease |
- ‹ previous
- 2 of 10
- next ›